Penicillins and Cephalosporins

Front Matter....Pages i-xiv
The Beta Lactam Antibiotics — Penicillins and Cephalosporins....Pages 1-5
Clinical Relevance of Ampicillin/Cloxacillin for IV Use....Pages 7-12
Experiences with Amoxicillin in Full-Term and Pre-Term Neonates....Pages 13-18
Comparative Activity of Amoxycillin, Ampicillin and Benzylpenicillin Against Streptococci Causing Bacterial Endocarditis....Pages 19-24
A Multicentre Study of Talampicillin and Ampicillin in General Practice....Pages 25-30
Pharmacological and Clinical Studies with Talampicillin, an Ester of Ampicillin....Pages 31-36
Pharmacokinetic Studies of Serum Levels and Urinary Excretion of Ticarcillin after Intravenous and Intramuscular Administration to Patients with Normal and Abnormal Renal Function....Pages 37-43
The Use of Ticarcillin in the Treatment of Acute Urinary Tract Infections....Pages 45-49
Microbiology of Carfecillin, The α-Phenyl Ester of Carbenicillin....Pages 51-55
Chemotherapeutic Activity of Carfecillin, the α-Phenyl Ester of Carbenicillin, in the Treatment of Experimental Mouse Infections....Pages 57-62
Pharmacological and Clinical Studies with Carfecillin, an Orally Administered Ester of Carbenicillin....Pages 63-69
Determination of Indanyl Carbenicillin in Urine with Blood....Pages 71-73
 In Vitro Activity and Clinical Use of Indanyl Carbenicillin....Pages 75-82
Clinical Experience with Geopen (Carbenicillin)....Pages 83-85
Indanyl Carbenicillin and Urinary Infections....Pages 87-92
Oral Treatment with Carindacillin in Patients Suffering from Urinary Tract Infections....Pages 93-97
Carindacillin in the Therapy of Urinary Tract Infections....Pages 99-101
Urinary Levels of Carindacillin in the Pediatric Age....Pages 103-107
Clinical Pharmacological Studies with Bacampicillin....Pages 109-114
Clinical and Bacteriological Study on Bacampicillin in Skin and Soft Tissue Infections....Pages 115-121
Bacampicillin in Respiratory Tract and Urinary Tract Infections....Pages 123-129
Clinical Study of Bacampicillin in Urinary Tract Infections — A Comparison with Ampicillin....Pages 131-136
Bacampicillin in Acute Tonsillitis....Pages 137-143
Clinical Study on Bacampicillin in Otitis Media Acuta and Sinusitis Acuta....Pages 145-150
Clinical, Bacteriological, and Pharmacological Study of Bacampicillin in Chronic Maxillary Sinsusitis....Pages 151-157
Mecillinam and Pivmecillinam — New Beta-Lactam Antibiotics with High Activity Against Gram-Negative Bacilli....Pages 159-165
The Disposition of Mecillinam and Pivmecillinam in Man....Pages 167-171
Plasma Profile & Urinary Excretion of Mecillinam after Pivmecillinam....Pages 173-181
Mecillinam: Factors Affecting in Vitro Activity....Pages 183-189
The Activity of Mecillinam (FL1060), in Combination with Other Antibiotics, Against H. Influenzae and Streptococcus Faecalis....Pages 191-198
Laboratory and Clinical Studies with Mecillinam....Pages 199-203
A Clinical Investigation of Pivmecillinam, a Novel ß-Lactam Antibiotic, in the Treatment of Urinary Tract Infections....Pages 205-210
Antibacterial Activity of Eight Cephalosporins (Cefamandole Included) on Two Common Respiratory Pathogens (Haemophilus Influenzae and Diplococcus Pneumoniae)....Pages 211-218
Relationship between Lytic and Inhibitory Concentrations of Cephalosporins....Pages 219-222
Cephacetrile: Plasma Concentrations during and after Constant Infusion....Pages 223-227
Clinical Evaluation of Cefoxitin....Pages 229-234
Synergistic Interaction of Cephalosporins and Human Serum on Gram-Negative Bacteria....Pages 235-240
A Comparative Study of Ceftezol (Demethyl-Cefazolin) and Cefazolin: Absorption, Distribution and Metabolism....Pages 241-246
In Vitro and in Vivo Evaluation of Two New Orally Active Cephalosporin Derivatives....Pages 247-252
A New Parenteral Cephalosporin. SK&F 59962: Serum Levels and Urinary Recovery in Man....Pages 253-257
Pharmacokinetics of Cephradine....Pages 259-262
Studies on the Diffusion of Cephradine and Cephalothin into Human Tissue....Pages 263-269
Dosage Schedule of Antimicrobial Agents....Pages 271-276
Schedule of Intermittent Cephalothin Therapy....Pages 277-282
Absorption and Excretion Studies of Cephalosporins in Human Subjects....Pages 283-292
Ocular Penetration and Clinical Evaluation of Ceftezole for Ocular Infections....Pages 293-298
Preliminary Studies of the Penetration of Cephacetrile (Celospor ® ) into Human Cerebrospinal Fluid....Pages 299-304
Tissue Concentrations of Cefazolin in Man....Pages 305-310
Cephazolin Sodium — An in Vivo and in Vitro Evaluation of 100 Patients with Urinary Tract Infections in a District General Hospital....Pages 311-314
Treatment of Bacterial Pneumonia with Cefazolin....Pages 315-318
Identification of Beta-Lactamases by Analytical Isoelectric Focusing....Pages 319-324
The Combined Effect of Protein-Binding and Beta-Lactamases on the Activity of Penicillins and Cephalosporins....Pages 325-329
Bacterial Biotransformation of Ampicillin, Amoxicillin and Oxacillin in Vitro and in Urine of Patients with Bacteriuria....Pages 331-336
Substrate Profiles of β-Lactamases Against Newer β-Lactam-antibiotics....Pages 337-340
Beta-Lactamase Resistance of Cephazolin and Other Cephalosporins....Pages 341-346
Interactions of New Cephalosporins with Some Cephalosporinases....Pages 347-353
The Activity of Haemophilus Influenzae ß-Lactamase....Pages 355-359
Ampicillin Resistance and Beta-Lactamase Activity in Clinical Isolates of Shigella Sonnei....Pages 361-364
Inhibition of Bacterial Cell Wall Synthesis by Amphomycin....Pages 365-369
Effect of Primycin on DNA....Pages 371-377
Pipemidic Acid, a New Synthetic Antibacterial Agent....Pages 379-384
Clinical Studies of Pipemidic Acid in the Field of Pediatrics....Pages 385-390
In Vitro and in Vivo Studies on Antibiotics from Skin Micrococcaceae....Pages 391-396
Antimicrobial Substances from the Larval Isolates of Greater Wax Moth, Galleria Mellonella L.....Pages 397-402
Advantages of New Tetracycline-Complexes in Human Therapy....Pages 403-410
Nifurpipone in Urinary Tract Acute Infections....Pages 411-416
The Use of Cinoxacin in Urinary Tract Infections....Pages 417-418
Back Matter....Pages 419-420